Dopamine Agents: all 740 studies that test it
Page 8 of 8. Open to participants first (58), then studies with results posted, then the rest; newest registration first within each.
- Memantine for the Treatment of Cognitive Dysfunction and Negative Symptoms in Patients With Chronic SchizophreniaTerminatedNCT00148616Phase 3
- Memantine for the Prevention of Cognitive Dysfunction and Negative Symptoms in Patients With Acute SchizophreniaTerminatedNCT00148590Phase 3
- Study on Chronic Hepatitis C Treatment With Interferon Alpha, Ribavirin and Amantadine in Naive PatientsCompletedNCT00146016Phase 3
- Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United StatesCompletedNCT00143026Phase 4
- Memantine in Patients With Chronic GlaucomaCompletedNCT00141882Phase 3
- The Effects of Memantine and Bupropion on Acute, Reinforcing, and Conditioned Effects of Cigarettes - 1CompletedNCT00136747Phase 1
- A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/LevodopaCompletedNCT00134966Phase 3
- Peginterferon Alfa-2a, Ribavirin, Amantadine/Placebo in Hepatitis C Virus (HCV)-Genotype-1-Infection (PRAMA)Status unknownNCT00127777Phase 4
- Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD)WithdrawnNCT00127114Phase 4
- Potentiation of Procedural Motor Learning in Health and DiseaseTerminatedNCT00126087Phase 4
- A Study of Duloxetine in the Treatment of FibromyalgiaCompletedNCT00125892Phase 3
- Duloxetine Compared With Placebo in the Prevention of Relapse in Generalized Anxiety DisorderCompletedNCT00122863Phase 3
- A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety DisorderCompletedNCT00122850Phase 3
- A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety DisorderCompletedNCT00122837Phase 3
- Duloxetine Compared With Placebo in Patients With Generalized Anxiety DisorderCompletedNCT00122824Phase 3
- Triple Therapy With Peg-Interferon Alfa-2b/Ribavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2b/Ribavirin for Previous Hepatitis C Virus (HCV) Non RespondersTerminatedNCT00122629Phase 3
- Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With DyslexiaStatus unknownNCT00111371Phase 4
- An Evaluation of the Safety and Efficacy of Memantine in Patients With Acute Mania Associated With Bipolar I DisorderCompletedNCT00106405Phase 2
- Improved Language Acquisition With LevodopaCompletedNCT00103805Phase 4
- Dopaminergic Enhancement of Learning and Memory in AphasiaCompletedNCT00102869Phase 4
- Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment in Schizophrenia PatientsCompletedNCT00097942Phase 2
- An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's DiseaseCompletedNCT00097916Phase 3
- Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's DiseaseCompletedNCT00096720Phase 2
- Levetiracetam Treatment of L-dopa Induced DyskinesiasCompletedNCT00076674Phase 2
- Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients With DepressionCompletedNCT00073411Phase 3
- Duloxetine vs. Active Comparator in the Treatment of Patients With DepressionCompletedNCT00071695Phase 4
- Duloxetine vs. Active Comparator for the Treatment of DepressionCompletedNCT00067912Phase 4
- Study of Duloxetine in Elderly Patients With Major Depressive DisorderCompletedNCT00062673Phase 3
- A Study for the Treatment of Painful Diabetic NeuropathyCompletedNCT00058968Phase 3
- Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major DepressionCompletedNCT00042575Phase 3
- Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major DepressionCompletedNCT00042562Phase 3
- Clinical Trial of Memantine for Major DepressionCompletedNCT00040261Phase 3
- Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and PainCompletedNCT00036335Phase 3
- Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive DisorderCompletedNCT00036309Phase 3
- Prepulse Inhibition of Startle in Cocaine Dependence - 7CompletedNCT00015249Phase 1
- Riluzole to Treat Parkinson's DiseaseCompletedNCT00013624Phase 2
- Timing of Levodopa Treatment in Parkinson's DiseaseCompletedNCT00004733Phase 3
- Treatment of Huntington's Chorea With AmantadineCompletedNCT00001930Phase 2
- A Study to Evaluate the Use of Memantine In Combination With Anti-HIV Drugs to Treat AIDS Dementia Complex (ADC)CompletedNCT00000867Phase 2
- Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4CompletedNCT00000301Phase 2